T
Tsubota Laboratory Inc
TSE:4890
Tsubota Laboratory Inc
TSE:4890
Price:
305
JPY
1.33%
Market Closed
Market Cap:
¥7.9B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
T
|
Tsubota Laboratory Inc
TSE:4890
|
JP |
|
Gevo Inc
NASDAQ:GEVO
|
US |
|
Kuramoto Co Ltd
TSE:5216
|
JP |
|
Penumbra Inc
NYSE:PEN
|
US |
|
M
|
Magna International Inc
NYSE:MGA
|
CA |
|
C
|
Conduit Pharmaceuticals Inc
NASDAQ:CDT
|
US |
|
Inditrade Capital Ltd
BSE:532745
|
IN |
|
Kapuas Prima Coal Tbk PT
IDX:ZINC
|
ID |
|
I
|
Indonesia Energy Corp Ltd
AMEX:INDO
|
ID |
|
K
|
Kancera AB
F:3EE0
|
SE |
|
A
|
Alphabet Inc
MIL:GOOG
|
US |
|
H
|
HLE Glascoat Ltd
NSE:HLEGLAS
|
IN |
|
S
|
SMIFS Capital Markets Ltd
BSE:508905
|
IN |
|
Roche Holding AG
OTC:RHHBY
|
CH |
|
Marco Polo Marine Ltd
SGX:5LY
|
SG |
|
Metaplanet Inc
OTC:MTPLF
|
JP |
|
Shenzhen Changhong Technology Co Ltd
SZSE:300151
|
CN |
|
S
|
Sealink International Bhd
KLSE:SEALINK
|
MY |
|
A
|
Allied Machinery Co Ltd
SSE:605060
|
CN |
|
Fras Le SA
BOVESPA:FRAS3
|
BR |
|
I
|
ITC Hotels Ltd
NSE:ITCHOTELS
|
IN |
|
Li Auto Inc
HKEX:2015
|
CN |
Multiples-Based Value
The Multiples-Based Value of one Tsubota Laboratory Inc stock under the Base Case scenario is hidden JPY. Compared to the current market price of 305 JPY, Tsubota Laboratory Inc is hidden .
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Tsubota Laboratory Inc Multiples-Based Value
LOCKED
Multiples Across Competitors
Competitors Multiples
Tsubota Laboratory Inc Competitors
Tsubota Laboratory Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| JP |
T
|
Tsubota Laboratory Inc
TSE:4890
|
7.9B JPY | 11.1 | -19.7 | -18.1 | -17 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
883.9B USD | 13.6 | 42.8 | 28.9 | 30.8 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
585.2B USD | 6.2 | 21.8 | 15.2 | 18.6 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
237.5B GBP | 5.4 | 31.2 | 17.2 | 24.2 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4.1 | 19.7 | 11.6 | 13.1 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
299.1B USD | 4.6 | 16.4 | 10.1 | 12.3 | |
| CH |
|
Novartis AG
SIX:NOVN
|
236.4B CHF | 5.4 | 21.8 | 13.5 | 17.3 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD | 102.3 | -81.1 | 375.3 | 941.3 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.4 | 10.3 | 7.6 | 9 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
161B USD | 2.6 | 20.7 | 7.9 | 10.5 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
120B USD | 2.5 | 17 | 7.2 | 8.8 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
